ArticleAAPS PharmSciTech2025
Development, Characterization, and in vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer.
Alec M Diorio et al.PubMed ↗Publisher ↗
No numbers read from the abstract.